Establishment Labs Holdings Inc.

DB:3E0 Stock Report

Market Cap: €930.3m

Establishment Labs Holdings Management

Management criteria checks 3/4

Establishment Labs Holdings' CEO is Fillipo Caldini, appointed in Mar 2025, has a tenure of less than a year. total yearly compensation is $1.44M, comprised of 10.6% salary and 89.4% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth €1.04M. The average tenure of the management team and the board of directors is 3.3 years and 7.3 years respectively.

Key information

Fillipo Caldini

Chief executive officer

US$1.4m

Total compensation

CEO salary percentage10.55%
CEO tenureless than a year
CEO ownership0.1%
Management average tenure3.3yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Fillipo Caldini's remuneration changed compared to Establishment Labs Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-US$89m

Dec 31 2024US$1mUS$152k

-US$85m

Compensation vs Market: Fillipo's total compensation ($USD1.44M) is about average for companies of similar size in the German market ($USD1.25M).

Compensation vs Earnings: Insufficient data to compare Fillipo's compensation with company performance.

CEO

Fillipo Caldini (59 yo)

less than a year
Tenure
US$1,440,292
Compensation

Mr. Filippo Peter Caldini served as Interim Chief Executive Officer of Establishment Labs Holdings Inc. since March 1, 2025 until May 7, 2025 & serves as it's CEO since May 7, 2025 and was its President si...

Leadership Team

NamePositionTenureCompensationOwnership
Fillipo Caldini
Chief Executive Officerless than a yearUS$1.44m0.11%
€ 1.0m
Juan Chacon Quiros
Founder & Executive Director21.3yrsUS$2.60m5.07%
€ 47.1m
Rajbir Denhoy
Chief Financial Officer3.8yrsUS$1.12m0.40%
€ 3.7m
S. Mansbach
General Counsel2.8yrsUS$1.06m0.085%
€ 791.0k
Roberto de Mezerville
Chief Technology Officer7.3yrsno datano data
Salvador Santos Dada
Head of Special Projects9.3yrsUS$468.62kno data
Rosalyn Cole d'Incelli
SVP of Global Clinicalno datano datano data
Ivan Bilic
Senior Vice President of Commercial Operations - OUS1.4yrsno datano data
Jeff Ehrhardt
Senior VP & GM of North America1.3yrsno datano data
3.3yrs
Average Tenure
52yo
Average Age

Experienced Management: 3E0's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Juan Chacon Quiros
Founder & Executive Director12.3yrsUS$2.60m5.07%
€ 47.1m
Robert S. Langer
Member of Scientific Advisory Boardno datano datano data
Edward Schutter
Independent Director9.7yrsUS$209.17k1.29%
€ 12.0m
Nicholas Lewin
Chairman of the Board9.7yrsUS$224.96k3.85%
€ 35.8m
Ann Custin
Independent Non-Executive Director4.8yrsUS$202.46k0.091%
€ 847.0k
Leslie Gillin
Independent Director4.4yrsUS$190.67k0.072%
€ 674.4k
Alexandre Mendonca Munhoz
Member of Medical Advisory Boardno datano datano data
Dennis Hammond
Member of Medical Advisory Boardno datano datano data
Niamh Corduff
Member of Medical Advisory Boardno datano datano data
Ardeshir Bayat
Member of Scientific Advisory Boardno datano datano data
Bryan Slotkin
Independent Director4.8yrsUS$197.93k0.13%
€ 1.2m
Federico Mayo
Member of Medical Advisory Boardno datano datano data
7.3yrs
Average Tenure
54yo
Average Age

Experienced Board: 3E0's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 15:39
End of Day Share Price 2025/05/19 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Establishment Labs Holdings Inc. is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Neil ChatterjiB. Riley Securities, Inc.
Sam EiberBTIG
Marie ThibaultBTIG